Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes

By  

Drug Metabolism Letters, Vol. 10, Iss. 1, 2016-03 ,pp. : 56-64

Bentham Science Publishers

Access to resources Recommend Favorite

New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme

By Wang Bo   Yang Li-Ping   Zhang Xiao-Zhuang   Huang Shui-Qing   Bartlam Mark   Zhou Shu-Feng  

Drug Metabolism Reviews, Vol. 41, Iss. 4, 2009-11 ,pp. : 573-643

Informa Healthcare

Access to resources Recommend Favorite

Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoids

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 8, 2015-11 ,pp. : 552-563

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Evaluation of Ondansetron Binding Interactions with Human Cytochrome P450 Enzymes CYP3A4 and CYP2D6

By  

Drug Metabolism Letters, Vol. 4, Iss. 1, 2010-01 ,pp. : 25-30

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity

By Neafsey Patricia  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 334-361

Taylor & Francis Ltd

Access to resources Recommend Favorite